Protara Therapeutics, Inc. (TARA)

Protara Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 22, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Cap	275	286	185	21	30	76
Market Cap Growth	111.40%	54.36%	766.03%	-29.24%	-60.18%	-72.06%
Enterprise Value	104.97	132.18	18.1	-39.73	-48.71	-9
Last Close Price	4.89	5.33	5.28	1.88	2.68	6.75
PB Ratio	1.51	1.45	1.11	0.31	0.30	0.47
P/TBV Ratio	1.27	1.16	0.65	0.31	0.30	0.47
EV/EBITDA Ratio	-	-	-	0.92	0.73	0.19
EV/EBIT Ratio	-	-	-	0.91	0.73	0.19
EV/FCF Ratio	-	-	-	1.06	1.83	0.26
Debt / Equity Ratio	0.01	0.01	0.02	0.07	0.05	0.04
Net Debt / Equity Ratio	-0.73	-0.77	-0.99	-0.88	-0.76	-0.52
Net Debt / EBITDA Ratio	1.91	2.37	3.40	1.39	1.17	1.77
Net Debt / FCF Ratio	2.11	2.70	4.62	1.60	2.93	2.39
Quick Ratio	15.22	14.22	15.54	10.67	14.70	21.23
Current Ratio	15.69	14.58	15.71	11.17	15.01	21.66
Return on Equity (ROE)	-33.53%	-31.60%	-37.88%	-47.44%	-49.96%	-26.17%
Return on Assets (ROA)	-34.91%	-33.02%	-37.75%	-45.37%	-46.92%	-25.28%
Return on Invested Capital (ROIC)	-151.15%	-283.47%	-1031.24%	-270.01%	-131.47%	-86.61%
Return on Capital Employed (ROCE)	-36.72%	-34.98%	-40.41%	-48.36%	-48.62%	-25.77%
Buyback Yield / Dilution	-68.53%	-108.01%	-81.73%	-0.64%	-0.24%	-55.28%
Total Shareholder Return	-68.53%	-108.01%	-81.73%	-0.64%	-0.24%	-55.28%

Updated May 13, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q